A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma. Academic Article uri icon

Overview

publication date

  • December 1, 1992

Research

keywords

  • Antigens, Neoplasm
  • Genetic Therapy
  • HLA-A2 Antigen
  • Immunologic Factors
  • Immunotherapy, Active
  • Interleukin-2
  • Melanoma
  • Recombinant Fusion Proteins
  • Tumor Cells, Cultured

Identity

Scopus Document Identifier

  • 0027015406

Digital Object Identifier (DOI)

  • 10.1089/hum.1992.3.6-677

PubMed ID

  • 1482708

Additional Document Info

volume

  • 3

issue

  • 6